WOCKPHARMA

What Wockhardt promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q4 FY26

what the last two calls moved 15 tracked 1 delivered 4 missed 10 open
  • PBT Positive Status missed said Q3 FY23 Promised: turn completely PBT positive in 2 years from now Q4 FY26: Company reported PBT of INR 238 crores for FY26. This confirms the target for FY25 was not met.
  • Biosimilar Capacity revised up said Q4 FY25 Promised: double our capacities over the next 24 months and put up new facility Q4 FY26: Timeline accelerated: 'we will double our capacity in the next 12 to 15 months.'
  • Biosimilar Business Size on track said Q4 FY25 Promised: expect to double the business in the next 3 years Q4 FY26: Management reiterated the goal to double the business in the next 24-36 months. The business grew 27% in FY26, showing strong progress.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 15 tracked commitments for Wockhardt — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens